课题基金 / 基金详情

Using Medicaid data to advance care for people with schizophrenia at risk for HIV (Medicaid-DASH)

Using Medicaid data to advance care for people with schizophrenia at risk for HIV (Medicaid-DASH)
利用医疗补助数据促进对有艾滋病毒风险的精神分裂症患者的护理 (Medicaid-DASH)
批准号:
9903937
负责人:
Christina Mangurian
金额:
$24.98万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2023-03-31

项目摘要

项目成果

Christina Mangurian的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT People with severe mental illness (e.g., schizophrenia, bipolar disorder; SMI) are a socially marginalized population with up to ten times increased likelihood of being diagnosed with HIV compared to the general United States population. The parent grant (R01-MH112420) aims to investigate the increased HIV transmission risk, low testing rate, and potential HIV treatment gaps for people with SMI using a large, geographically diverse national retrospective longitudinal Medicaid cohort. The outcomes assessed by the parent grant, however, may be modified by membership in intersecting categories of social marginalization. Single-axis interventions that do not consider heterogeneities among vulnerable populations may not be effective in improving outcomes and achieving epidemic control. Therefore, research is needed to identify and assess the magnitude of outcome inequalities among the riskiest intersectional positions. Leveraging twelve years of Medicaid data (2001 through 2012), the major goal of this research is to assess the existence and magnitude of outcome inequalities along the HIV continuum of care, with respect to intersecting categories of social marginalization (e.g. schizophrenia diagnosis, race/ethnicity, sex, intravenous drug use, etc.). The diversity supplement seeks to provide mentored theoretical and methodological training for the candidate in the area of quantitative intersectionality research. The proposed career development aims are: (1) to develop foundational knowledge in intersectionality as a theoretical framework; and (2) to develop expertise in quantitative intersectionality research methods. Aligned with the career development objectives, the research goals of the proposed study are to: (a) research the cutting-edge quantitative intersectionality approaches to assess the existence and magnitude of HIV outcome inequalities within a large administrative database; (b) examine differential rates of HIV testing by intersecting categories of schizophrenia diagnosis, sex, age, history of intravenous drug use, and race/ethnicity in the R01 parent grant retrospective cohort; and (c) examine differential rates of treatment for HIV by intersecting categories of schizophrenia diagnosis, sex , age, history of intravenous drug use, and race/ethnicity in the R01 parent grant retrospective cohort. The evidence generated from this work could identify the riskiest intersectional positions to inform targeted, cost- effective, interventions to improve HIV testing and care outcomes among those most vulnerable. Additionally, the foundational knowledge of intersectionality as a theoretical framework, paired with the application of quantitative intersectionality methods to a large administrative data set, will position the candidate to have an impactful career as an independent investigator generating rigorous quantitative evidence demonstrating health inequities among socially marginalized populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Medicaid data to advance care for people with schizophrenia at risk for HIV (Medicaid-DASH)
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
Improving Metabolic Screening in Diverse Severely Mentally Ill Populations
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: